Your browser doesn't support javascript.
loading
Dose-dependent Effects of Unintended Splenic Irradiation After Neoadjuvant Radiochemotherapy for Esophageal Cancer.
Celik, Eren; Baues, Christian; Trommer, Maike; Fan, Jiaqi; Nadjiri, Lukas; Rosenbrock, Johannes; Linde, Philipp.
Afiliação
  • Celik E; Department of Radiation Oncology, CyberKnife and Radiation Therapy, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany; eren.celik@uk-koeln.de.
  • Baues C; Center for Integrated Oncology (CIO), University Hospital of Cologne, Faculty of Medicine and University of Cologne, Cologne, Germany.
  • Trommer M; Department of Radiation Oncology, CyberKnife and Radiation Therapy, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Fan J; Center for Integrated Oncology (CIO), University Hospital of Cologne, Faculty of Medicine and University of Cologne, Cologne, Germany.
  • Nadjiri L; Department of Radiation Oncology, CyberKnife and Radiation Therapy, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Rosenbrock J; Center for Integrated Oncology (CIO), University Hospital of Cologne, Faculty of Medicine and University of Cologne, Cologne, Germany.
  • Linde P; Department of Radiation Oncology, CyberKnife and Radiation Therapy, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
Anticancer Res ; 43(6): 2733-2739, 2023 Jun.
Article em En | MEDLINE | ID: mdl-37247933

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Terapia Neoadjuvante Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Anticancer Res Ano de publicação: 2023 Tipo de documento: Article País de publicação: Grécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Terapia Neoadjuvante Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Anticancer Res Ano de publicação: 2023 Tipo de documento: Article País de publicação: Grécia